Literature DB >> 6088218

Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.

D H Streeten, G H Anderson, T G Dalakos, D Seeley, J S Mallov, R Eusebio, F S Sunderlin, S Z Badawy, R B King.   

Abstract

The first half of this manuscript is devoted to a review of the methods used and the results obtained in the published measurements of the normal responses to tests of the three main types of hypothalamic-pituitary-adrenocortical (HPA) activity in man. These are, I, basal, unstressed activity leading to appropriate levels of total daily production of cortisol in the characteristic circadian pattern; II, responses to feedback stimulation of HPA activity by metyrapone administration; and III, responses to tests of the effects of stress on the HPA system including the effects of hypoglycemia, induced fever, vasopressin administration, and ACTH injections and infusions. The advantages and shortcomings of each type of procedure are discussed. The second half of this paper describes the authors' attempts to establish the limits of normality of standard and modified methods of evaluating the HPA system. The defined limits of normality have been used to assess the HPA function in 158 patients with known or suspected disorders of the HPA system. In normal controls, halfhourly plasma cortisol determinations established the normality of circadian and postprandial fluctuations and of mean plasma cortisol concentration, 6.2 +/- 0.3 (SEM) micrograms/dl, which were closely approximated by determinations every 6 h. Metyrapone, given in a dose of 500 mg every 2 h for 24 h increased urinary 17-OHCS excretion to 10.5-32.6 mg/day or to 1.7-7.8 times basal excretion rate. Increasing rates of insulin infusion disclosed significant relationships between resulting plasma glucose and cortisol concentrations. The slopes of the delta cortisol/delta glucose responses were similar after insulin infusions (0.46 +/- 0.05) and after insulin injections, 0.15 U/kg (0.43 +/- 0.09), and were always greater than 0.20 micrograms/mg. This index provides a useful objective measure of the normality of responses to hypoglycemic stress, 0.20-0.87 micrograms/mg. Adrenocortical responses to iv infusions of ACTH (cosyntropin 0.25 mg) may be equivocal at 2 h but are clear cut at 4, 6 and 8 h. Of 158 patients in whom hypopituitarism was known or suspected because of the presence of a pituitary tumor, acromegaly, hyperprolactinemia, or clinical features, HPA function was found to be entirely normal in 88 patients and partially or severely abnormal in the remaining 70 patients.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088218     DOI: 10.1210/edrv-5-3-371

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  17 in total

1.  Multiple primary endocrine failure: a case report.

Authors:  J V Mackel; E H Krikke
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

2.  Clinical factors associated with biochemical adrenal-cortisol insufficiency in hospitalized patients.

Authors:  Stephanie M Gwin; Annika K Khine; Anat Ben-Shlomo; James Mirocha; Ning-Ai Liu; Renee C Sheinin; Shlomo Melmed
Journal:  Am J Med       Date:  2014-03-13       Impact factor: 4.965

3.  Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyrapone.

Authors:  P I Hartzband; A J Van Herle; L Sorger; D Cope
Journal:  J Endocrinol Invest       Date:  1988-12       Impact factor: 4.256

4.  Filter paper cortisol profiles in secondary adrenocortical insufficiency.

Authors:  J S Sieratzki; C Gompels; K Poyser; J Beaman; D C Savage
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

5.  Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test.

Authors:  Z Lević; D Micić; J Nikolić; N Stojisavljević; D Sokić; S Janković; A Kendereski; M Mavra
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

6.  Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock.

Authors:  J L Moran; M J Chapman; M S O'Fathartaigh; A R Peisach; P R Pannall; P Leppard
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440

7.  Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology.

Authors:  J Coste; G Strauch; M Letrait; X Bertagna
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

8.  Comparison of insulin hypoglycemia and short metyrapone tests in patients with pituitary disease.

Authors:  K Achenbach; W Oelkers
Journal:  Klin Wochenschr       Date:  1985-08-16

9.  The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue.

Authors:  D H Streeten; G H Anderson
Journal:  Clin Auton Res       Date:  1998-04       Impact factor: 4.435

10.  Cellular stress and glucocorticoid hormones protect L929 mouse fibroblasts from tumor necrosis factor alpha cytotoxicity.

Authors:  M C Pagliacci; G Migliorati; M Smacchia; F Grignani; C Riccardi; I Nicoletti
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.